Natco Pharma launches epilepsy treatment drug Brivaracetam in India

Brivaracetam, indicated towards treatment of epilepsy, is developed by UCB Pharma and currently marketed in India by Dr Reddy#39;s under brand name Briviact.

from Moneycontrol Business News https://ift.tt/3dMFQHp